Literature DB >> 15563004

Development of a whole body physiologically based model to characterise the pharmacokinetics of benzodiazepines. 1: Estimation of rat tissue-plasma partition ratios.

Ivelina Gueorguieva1, Ivan A Nestorov, Susan Murby, Sophie Gisbert, Brent Collins, Kelly Dickens, Judith Duffy, Ziad Hussain, Malcolm Rowland.   

Abstract

Three methods for estimation of the equilibrium tissue-to-plasma partition ratios (Kp values) in the presence of tissue concentration time data have been investigated. These are the area method, the open loop (tissue specific) method and the whole body model(closed loop) method, each with different model assumptions. Additionally, multiple imputations, a technique for dealing with deficiencies in data sets (i.e., missing tissues) is used. The estimated Kp values by the three methods have been compared and the limitations and advantages of each approach drawn. The area method, which is essentially model free, gives only a crude estimate of Kp without making any statement of its uncertainty; whereas both the open and closed loop methods provide an estimate of this. The closed loop method, where the most assumptions are made, is the approach that gives the best overall estimates of Kp, which was confirmed by comparing the predicted concentration-time profiles with experimental data. Although the estimates from the closed loop method, as well as the other two methods, are conditioned on the data, they are the most reliable for both propagating parameter variability and uncertainty through a whole body physiologically based model, as well as for extrapolation to human. A series of benzodiazepines, namely alprazolam, chlordiazepoxide, clobazam, diazepam, flunitrazepam, midazolam and triazolam in rat is used as a case study in the current investigation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15563004     DOI: 10.1023/b:jopa.0000042737.14033.c6

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  50 in total

1.  Precision and sensitivity of pharmacokinetic models for cancer risk assessment: tetrachloroethylene in mice, rats, and humans.

Authors:  F Y Bois; L Zeise; T N Tozer
Journal:  Toxicol Appl Pharmacol       Date:  1990-02       Impact factor: 4.219

2.  Differential reinforcement of low rate performance, pharmacokinetics and pharmacokinetic-pharmacodynamic modeling: independent interaction of alprazolam and caffeine.

Authors:  C E Lau; Y Wang; J L Falk
Journal:  J Pharmacol Exp Ther       Date:  1997-06       Impact factor: 4.030

3.  Validation of assay methodology used in pharmacokinetic studies.

Authors:  L Aarons; S Toon; M Rowland
Journal:  J Pharmacol Methods       Date:  1987-07

4.  Quantitative structure-pharmacokinetics relationships: I. Development of a whole-body physiologically based model to characterize changes in pharmacokinetics across a homologous series of barbiturates in the rat.

Authors:  G E Blakey; I A Nestorov; P A Arundel; L J Aarons; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1997-06

5.  Pharmacokinetic-pharmacodynamic modeling of stimulatory and sedative effects of alprazolam: timing performance deficits.

Authors:  C E Lau; A C Heatherington
Journal:  J Pharmacol Exp Ther       Date:  1997-12       Impact factor: 4.030

6.  Characterization of six in vitro reactions mediated by human cytochrome P450: application to the testing of cytochrome P450-directed antibodies.

Authors:  J Schmider; D J Greenblatt; L L von Moltke; J S Harmatz; S X Duan; D Karsov; R I Shader
Journal:  Pharmacology       Date:  1996-02       Impact factor: 2.547

7.  Pharmacokinetics of diazepam in the rat: influence of a carbon tetrachloride-induced hepatic injury.

Authors:  J M Díaz-García; J Oliver-Botana; D Fos-Galve
Journal:  J Pharm Sci       Date:  1992-08       Impact factor: 3.534

8.  In vitro and in vivo assessment of hepatic and extrahepatic metabolism of diazepam in the rat.

Authors:  Y Igari; Y Sugiyama; Y Sawada; T Iga; M Hanano
Journal:  J Pharm Sci       Date:  1984-06       Impact factor: 3.534

9.  Regional blood flow in conscious resting rats determined by microsphere distribution.

Authors:  I Kuwahira; N C Gonzalez; N Heisler; J Piiper
Journal:  J Appl Physiol (1985)       Date:  1993-01

10.  Physiologically based pharmacokinetics and the risk assessment process for methylene chloride.

Authors:  M E Andersen; H J Clewell; M L Gargas; F A Smith; R H Reitz
Journal:  Toxicol Appl Pharmacol       Date:  1987-02       Impact factor: 4.219

View more
  9 in total

1.  A comment on the application of drug tissue-plasma partition coefficients K(p) in eliminating organs to calculation of volume of distribution at steady state.

Authors:  Sven Björkman
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-12       Impact factor: 2.745

2.  A comment on the "correction" of tissue-plasma partition coefficients for drug extraction in eliminating organs by Sven Björkman.

Authors:  Ivelina Gueorguieva; Malcolm Rowland
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-12       Impact factor: 2.745

3.  Physiologically based pharmacokinetic modeling of drug disposition in rat and human: a fuzzy arithmetic approach.

Authors:  Kok-Yong Seng; Ivan Nestorov; Paolo Vicini
Journal:  Pharm Res       Date:  2008-03-25       Impact factor: 4.200

4.  Whole body physiologically based modelling of β-blockers in the rat: events in tissues and plasma following an i.v. bolus dose.

Authors:  S Y A Cheung; T Rodgers; L Aarons; I Gueorguieva; G L Dickinson; S Murby; C Brown; B Collins; M Rowland
Journal:  Br J Pharmacol       Date:  2017-12-01       Impact factor: 8.739

5.  Evaluation and calibration of high-throughput predictions of chemical distribution to tissues.

Authors:  Robert G Pearce; R Woodrow Setzer; Jimena L Davis; John F Wambaugh
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-10-14       Impact factor: 2.745

6.  Use of partition coefficients in flow-limited physiologically-based pharmacokinetic modeling.

Authors:  Matthew D Thompson; Daniel A Beard; Fan Wu
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-05-26       Impact factor: 2.745

7.  Linking preclinical and clinical whole-body physiologically based pharmacokinetic models with prior distributions in NONMEM.

Authors:  Grant Langdon; Ivelina Gueorguieva; Leon Aarons; Mats Karlsson
Journal:  Eur J Clin Pharmacol       Date:  2007-03-08       Impact factor: 2.953

Review 8.  Drug structure-transport relationships.

Authors:  Michael S Roberts
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-11-24       Impact factor: 2.745

9.  Mechanistic approaches to volume of distribution predictions: understanding the processes.

Authors:  Trudy Rodgers; Malcolm Rowland
Journal:  Pharm Res       Date:  2007-03-20       Impact factor: 4.580

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.